RxDoctor Payments Data

Celia Padron

General Practice · Doral, FLNPI 1013961705

Payments from drug & device makers

What this record shows

4 manufacturers reported payments, led by Chiesi USA, Inc. at 56.8% of the total.

$915in general payments, 2019–2025

Across 22 payments — averaging $41.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$519
  • AbbVie$144
  • AstraZeneca$128
  • QOL Medical, LLC$123
$907,353in research payments, 2019–2025

Across 32 payments — averaging $28,355 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$513K
  • AstraZeneca$229K
  • AbbVie$145K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$12K
  • UCB Biosciences Inc.$9K

What the payments were for

  • Travel & lodging$39443%
  • Food & beverage$52057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Chiesi USA, Inc.2$519
AbbVie4$144
AstraZeneca2$128
QOL Medical, LLC14$123

How this compares

$915 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Allopurinol11$41

Paid to pharmacies, not to this prescriber.

Other general practice in Doral

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →